Literature DB >> 2959470

An ordered pathway of snRNP binding during mammalian pre-mRNA splicing complex assembly.

A Bindereif1, M R Green.   

Abstract

We have studied the assembly, composition and structure of splicing complexes using biotin-avidin affinity chromatography and RNase protection assays. We find that U1, U2, U4, U5 and U6 snRNPs associate with the pre-mRNA and are in the mature, functional complex. Association of U1 snRNP with the pre-mRNA is rapid and ATP independent; binding of all other snRNPs occurs subsequently and is ATP dependent. Efficient binding of U1 and U2 snRNPs requires a 5' splice site or a 3' splice site/branch point region, respectively. Both sequence elements are required for efficient U4, U5 and U6 snRNP binding. Mutant RNA substrates containing only a 5' splice site or a 3' splice site/branch point region are assembled into 'partial' splicing complexes, which contain a subset of these five snRNPs. RNase protection experiments indicate that in contrast to U1 and U2 snRNPs, U4, U5 and U6 snRNPs do not contact the pre-mRNA. Based upon the time course of snRNP binding and the composition of sucrose gradient fractionated splicing complexes we suggest an assembly pathway proceeding from a 20S (U1 snRNP only) through a 40S (U1 and U2 snRNPs) to the functional 60S splicing complex (U1, U2, U4, U5 and U6 snRNPs).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2959470      PMCID: PMC553648          DOI: 10.1002/j.1460-2075.1987.tb02520.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  34 in total

1.  U1, U2, and U4/U6 small nuclear ribonucleoproteins are required for in vitro splicing but not polyadenylation.

Authors:  S M Berget; B L Robberson
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

2.  Stepwise assembly of a pre-mRNA splicing complex requires U-snRNPs and specific intron sequences.

Authors:  D Frendewey; W Keller
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

3.  RNA splicing products formed with isolated fractions from HeLa cells are associated with fast-sedimenting complexes.

Authors:  K K Perkins; H M Furneaux; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

4.  The 3' splice site of pre-messenger RNA is recognized by a small nuclear ribonucleoprotein.

Authors:  B Chabot; D L Black; D M LeMaster; J A Steitz
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

5.  Assembly in an in vitro splicing reaction of a mouse insulin messenger RNA precursor into a 60-40S ribonucleoprotein complex.

Authors:  G Kaltwasser; S G Spitzer; C J Goldenberg
Journal:  Nucleic Acids Res       Date:  1986-05-12       Impact factor: 16.971

6.  Psoriasis and Raynaud's phenomenon associated with autoantibodies to U1 and U2 small nuclear ribonucleoproteins.

Authors:  W H Reeves; D E Fisher; R Wisniewolski; A B Gottlieb; N Chiorazzi
Journal:  N Engl J Med       Date:  1986-07-10       Impact factor: 91.245

Review 7.  Splicing of messenger RNA precursors.

Authors:  R A Padgett; P J Grabowski; M M Konarska; S Seiler; P A Sharp
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

8.  Specific small nuclear RNAs are associated with yeast spliceosomes.

Authors:  C W Pikielny; M Rosbash
Journal:  Cell       Date:  1986-06-20       Impact factor: 41.582

9.  Heterogeneous nuclear ribonucleoproteins: role in RNA splicing.

Authors:  Y D Choi; P J Grabowski; P A Sharp; G Dreyfuss
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

10.  Multiple factors including the small nuclear ribonucleoproteins U1 and U2 are necessary for pre-mRNA splicing in vitro.

Authors:  A R Krainer; T Maniatis
Journal:  Cell       Date:  1985-10       Impact factor: 41.582

View more
  121 in total

1.  Prespliceosomal assembly on microinjected precursor mRNA takes place in nuclear speckles.

Authors:  I Melcák; S Melcáková; V Kopský; J Vecerová; I Raska
Journal:  Mol Biol Cell       Date:  2001-02       Impact factor: 4.138

2.  Initial recognition of U12-dependent introns requires both U11/5' splice-site and U12/branchpoint interactions.

Authors:  M J Frilander; J A Steitz
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

3.  In vitro selection of exonic splicing enhancer sequences: identification of novel CD44 enhancers.

Authors:  G Woerfel; A Bindereif
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

4.  Functional and physical interactions between components of the Prp19p-associated complex.

Authors:  Chun-Hong Chen; Wan-Chin Yu; Twee Y Tsao; Lian-Yung Wang; Hau-Ren Chen; Jui-Yen Lin; Wei-Yü Tsai; Soo-Chen Cheng
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

5.  Evidence for a base-pairing interaction between U6 small nuclear RNA and 5' splice site during the splicing reaction in yeast.

Authors:  H Sawa; J Abelson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

6.  The spliceosome assembly pathway in mammalian extracts.

Authors:  S F Jamison; A Crow; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

7.  Unusual branch point selection involved in splicing of the alternatively processed Calcitonin/CGRP-I pre-mRNA.

Authors:  G J Adema; R A Bovenberg; H S Jansz; P D Baas
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

8.  Oligonucleotide-targeted degradation of U1 and U2 snRNAs reveals differential interactions of simian virus 40 pre-mRNAs with snRNPs.

Authors:  Z Q Pan; H Ge; X Y Fu; J L Manley; C Prives
Journal:  Nucleic Acids Res       Date:  1989-08-25       Impact factor: 16.971

9.  UACUAAC is the preferred branch site for mammalian mRNA splicing.

Authors:  Y A Zhuang; A M Goldstein; A M Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

10.  Rds3p is required for stable U2 snRNP recruitment to the splicing apparatus.

Authors:  Qiang Wang; Brian C Rymond
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.